Discover Southside Bancshares' Q1 2025 insights: robust $1.9B loan pipeline, strategic C&I growth, and focused margin improvements.

Discover Verona Pharma's Q1 2025 earnings report, featuring Ohtuvayre's rapid adoption, sales milestones, and global expansion.

The growth factor in investing refers to companies that grow their revenue and earnings at rates significantly above the ...

Q1 2025 Management View CEO Marty Birmingham highlighted the transformative impact of the late 2024 investment securities ...

Q1 2025 Management View Christophe Beck, Chairman & CEO, highlighted strong Q1 2025 results with organic sales growth of 3% and a 12% increase in EPS. He attributed this success to market share gains, ...

Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & loss statements.